Back to Agenda
DIA Global Annual Meeting - Opening DIAmond and Plenary Session
Session Chair(s)
Barbara Lopez Kunz, MBA, MS, MSC
CEO | Director, Caidya, United States
We are excited to welcome you to the DIA 2021 Virtual Global Annual Meeting
Join us for the Global Annual Meeting Welcome Remarks, Keynote Address, and Opening DIAmond Session!
Keynote Address: Kenneth Frazier, JD, Chairman of the Board and Chief Executive Officer, Merck & Co.
For most of us, the novel coronavirus represents an unprecedented time in our lives. However, history is full of accounts of humans grappling with viral invaders, and the positive innovations and learnings that we derive from these circumstances. Ken Frazier, Chairman and CEO of Merck, reflects on the discoveries that were made during pandemics of the past and their durable effects on science and society. Mr. Frazier also discusses the adaptations and accelerations required to develop vaccines and therapeutics to address the current pandemic, and their implications for the future of drug development. The lasting transformations of the COVID-19 pandemic may yet to be fully characterized, but we know they will be documented in the history books.
Opening Plenary Panel: Combating Misinformation in Health and Health Care
The COVID-19 era has been characterized by a strong anti-science bias among large swaths of the public in many countries. This includes those who deny the existence of COVID; those who oppose vaccines based on spurious science, correlation that does not reflect causality, or an unsupported belief that vaccines are untrustworthy or harmful; those who believe that science comes from an elite that may not have the best interests of the general public at heart; and many others.
All of these beliefs pose significant challenges to public health efforts to contain the spread of COVID and encourage widespread vaccination. The problem is compounded by the tremendous amounts of misinformation that have been circulating since the beginning of the pandemic. This misinformation has been promulgated through many channels, particularly on social media. While reputable sources have made many attempts to remove or discredit such information, these efforts have been far from successful. People also continue to receive misinformation from family, friends, and public figures.
- How does misinformation about health and health care spread? Why do people believe it?
- What do we know about how to successfully help people identify and question misinformation?
- Who is best positioned to counter misinformation about COVID, and what do we know about how to do so effectively?
- Are there specific approaches to combating misinformation that can help address known disparities in health and health care, particularly those that are COVID-related?
Learning Objective : Identify two ways in which misinformation about health and health care spread; Identify one way in which to counter misinformation about COVID-19 effectively; Describe how known disparities in health and health care relate to the spread of misinformation about COVID-19.
Speaker(s)
Judith Ng-Cashin, MD
Chief Executive Officer and President, JNC Consulting, United States
Opening Remarks
Emer Cooke, MBA, MSC
Chair, ICMRA; Executive Director, European Medicines Agency, Netherlands
Honorary Co-Chair
Janet Woodcock, MD
Retired, Principal Deputy Commissioner, FDA , United States
Honorary Co-Chair
Yasuhiro Fujiwara, MD, PHD
Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Honorary Co-Chair
Michael Rosenblatt, MD
Advisory Partner, Ascenta Capital, United States
Introduction of Keynote Speaker
Kenneth Frazier, JD
Chairman of the Board and Chief Executive Officer, Merck & Co., Inc., United States
Keynote Speaker
Susan Winckler, JD
Chief Executive Officer, Reagan-Udall Foundation for the FDA, United States
Moderator: Combating Misinformation in Health and Health Care
Briony Swire-Thompson
Senior Research Scientist, Lazer Lab, Northeastern University Network Science Institute, United States
Panelist
Brian Southwell, PHD
Senior Director, Science in the Public Sphere, Center for Communication Science, RTI International, United States
Panelist
Melanie Carr
Head of Stakeholders and Communication Division, European Medicines Agency, Netherlands
Panelist
Richardae Araojo, PHARMD, MS
Associate Commissioner for Minority Health, Director, Office of Minority Health , FDA, United States
Panelist
Have an account?